Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Clinical waste licence

28th Jun 2005 16:28

3DM Worldwide PLC28 June 2005 Press Release 28 June 2005 3DM Worldwide plc ("3DM" or "the Company") 3DM signs up a licensee for processing clinical waste 3DM Worldwide plc (AIM:TDM), which has developed and is now exploiting a plasticpolymer moulding process ("PIM process"), is pleased to announce that MedicalWaste Solutions Limited has signed a licence agreement with GW Butler Limited, aBradford-based waste management company, to use the 3DM proprietary system forprocessing clinical waste. This is the first licence that 3DM has granted inthe sector of clinical waste. Medical Waste Solutions is 85% owned by 3DM Environmental Limited with thebalancing shareholding belonging to the independent management. 3DM Worldwideplc have management control (with an option to purchase) 3DM EnvironmentalLimited which owns the intellectual property in this proprietary process. Established in 1933, GW Butler is a waste management company with clinical wastetreatment facilities. GW Butler specialises in the collection and disposal ofclinical waste mainly from the NHS, offering both 'bulk' collection andcontainer exchange services. Under the terms of the licence, Medical Waste Solutions will install a densifieronto GW Butler's Tempico Rotoclave, an advanced rotary auotclave which processeswaste. This densifier will allow the output from the Tempico Rotoclave toproduce a sterilised end product from clinical waste which can then be used inthe PIM process. The licence agreement provides for a royalty to be paid to Medical WasteSolutions under a formula linked to price and volume. This agreement is to runinitially for a period of 10 years. Charles Everson, Managing Director of Medical Waste Solutions Limited, said: "Under this licence we have brought together technologies from differentindustries to provide a complete clinical waste treatment process which does notrely on incineration and it does not rely on the use of landfill. Instead itrelies on a three stage process which allows 95% of the clinical waste stream tobe recycled into new products via the PIM process." Peter Oldham, Managing Director of 3DM Worldwide plc, said: "The technologyprovided by Medical Waste Solutions is an innovative, cost effective andenvironmentally friendly method of treating unwanted clinical waste. Theprocess turns waste into a sterile, moisture reduced, densified mixed polymerand other material flock that could then be used in the 3DM process for newapplications. "Currently the NHS produces in excess of 250,000 tonnes of clinical waste perannum and we hope that this licence will provide us with an entry point intothis sizeable market." - Ends - For further information: 3DM Worldwide PLC Ken Brooks, Chairman Tel: +44 (0) 1993 779 468 [email protected] www.3dmworldwide.com Medical Waste Solutions Limited Charles Everson, Managing Director Tel: +44 (0) 1642 353 537 [email protected] www.medicalwastesolutions.co.uk Media enquiries: Abchurch Henry Harrison-Topham / Katherine Murphy Tel: +44 (0) 20 7398 7705 [email protected] www.abchurch-group.com Notes to editors 3DM Worldwide plc is a leader in plastics technology intellectual property, andwas admitted to AIM in October 2002. 3DM acquired two plastics manufacturing processes in 2001: Powder ImpressionMoulding ("PIM") and 3-Dimensional Blow Moulding, the latter giving 3DM itsname. The PIM process allows the production of a strengthened plastic composite thathas the strength and other comparable properties of metal. It is a low pressuremoulding process suitable for the production of very large parts. There aremany varied applications in industry where there is a need for overall strengthand rigidity combined with weight savings. Significant capital and toolingsavings can be made, because the methodology of the process utilises anon-pressure method. There are many and varied potential PIM applications andit is ideal for those wishing to produce parts that may be large, light weightand durable. Specific applications include manufacturing of a wide range ofproducts in high volume global markets such as Building Products, Construction,Automotive, Marine, Aviation, and White Goods. 3DM's strategy with the PIM process is to offer this technology as analternative means of making large complex moulds, but also as a means ofreplacing alternative materials like metal or fibreglass. 3DM also believesthat the PIM process offers the potential for a significant rise in the use ofrecycled material to make a product which itself would be recyclable at the endof its useful life. The 3-Dimensional Blow Moulding process facilitates the manufacture of complexcomponents or component sub-assemblies of differing materials in a single mould. This reduces the number of parts in manufacturing, creating significant costsavings through diminished labour operations and attendant costs as well as areduction in the weight of cumulative parts. In addition, there is theopportunity to add non-plastic materials, and to vary the formula appropriate tocustomer requirements. Most of the exploratory work with this process has beenwith the automotive industry, where there is a constant need for more complexassemblies. This also applies to the medical industry, where similaropportunities exist, but with a wider spectrum of products. This information is provided by RNS The company news service from the London Stock Exchange

Related Shares:

ENRT.L
FTSE 100 Latest
Value7,964.18
Change50.93